About Aton Pharma
Aton Pharma, Inc. is a global specialty pharmaceutical company providing unique medicines to patients around the world. With seven products and sales in 32 countries, we are a global leader in providing essential treatments for rare diseases. We are a patient-focused company with a culture dedicated to improving the quality of life for people who need our medicines.
For more information about Aton Pharma, visit our Web site at www.atonrx.com or call us at 1-877-ATON-549 (1-877-286-6549).
Aton PatientCARESM Program
The Aton PatientCARESM program is a valuable source of information for MEPHYTON® patients.
If your patients have a question about MEPHYTON® or their managed care plan, they can call this toll-free hotline at 877-ATON-549 (877-286-6549), option 2, Monday-Friday 8 am-8 pm.
For faster service, advise your patients to have the following information on hand:
- Personal ID information
- Insurance ID number
- Your office’s contact information
A knowledgeable representative will answer any questions your patients might have about MEPHYTON® and insurance coverage.
Reporting Adverse Events
If you have any medical inquiries about MEPHYTON®, contact one of our medical specialists at 877-ATON-549 (877-286-6549), option 1, Monday-Friday 8 am-8 pm, or e-mail us at medicalaffairs@atonrx.com.
Indications
MEPHYTON® (PHYTONADIONE) is indicated in the following coagulation
disorders which are due to faulty formation of factors II, VII, IX, and X when
caused by vitamin K deficiency or interference with vitamin K activity.
MEPHYTON tablets are indicated in: anticoagulant-induced prothrombin
deficiency caused by coumarin or indanedione derivatives; hypoprothrombinemia
secondary to antibacterial therapy; hypoprothrombinemia secondary
to administration of salicylates; hypoprothrombinemia secondary to
obstructive jaundice or biliary fistulas but only if bile salts are administered
concurrently, since otherwise the oral vitamin K will not be absorbed.
Important Safety Information
MEPHYTON (PHYTONADIONE) is contraindicated in patients with hypersensitivity to any component of this medication. An immediate coagulation effect should not be expected after administration. MEPHYTON will not counteract the anticoagulant action of heparin. Phytonadione is not a clotting agent, but overzealous therapy with vitamin K1 may restore conditions which originally permitted thromboembolic phenomena. Dosage should be kept as low as possible, and prothrombin time should be checked regularly. Failure to respond to vitamin K may indicate a congenital coagulation defect or that the condition being treated is unresponsive to vitamin K. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
PLEASE SEE FULL PRESCRIBING INFORMATION.
